Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide.
Boehringer Ingelheim’s core principles and vision guide our work with patient organisations. Learn about how we collaborate with patient organisations.
Transitioning the economy from a linear to a circular approach is a herculean task – but also an innovation that carries huge potential. Learn more here.
Water availability and quality affects many aspects of individual, societal and environmental health. Good health hinges on good water. Learn more here.
The Riding for the Disabled Association (RDA) provides therapy, achievement and enjoyment to people with disabilities all over the UK. Learn more here.